Healthcare provider profile · identity verified

Dorian Denise Moore, MD

Internal Medicine · ANN ARBOR, MI · NPI 1194741447

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	453	113
Amlodipine Besylate	Amlodipine Besylate	445	119
Atorvastatin Calcium	Atorvastatin Calcium	361	106
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	325	51
Losartan Potassium	Losartan Potassium	310	80
Omeprazole	Omeprazole	253	73
Alprazolam	Alprazolam	250	42
Hydrochlorothiazide	Hydrochlorothiazide	225	66
Simvastatin	Simvastatin	221	54
Lisinopril	Lisinopril	207	58
Metformin Hcl	Metformin Hcl	207	51
Rosuvastatin Calcium	Rosuvastatin Calcium	190	50
Metoprolol Succinate	Metoprolol Succinate	173	39
Gabapentin	Gabapentin	170	40
Albuterol Sulfate Hfa	Albuterol Sulfate	161	63
Fluticasone Propionate	Fluticasone Propionate	147	57
Furosemide	Furosemide	147	52
Eliquis	Apixaban	139	36
Zolpidem Tartrate	Zolpidem Tartrate	129	23
Duloxetine Hcl	Duloxetine Hcl	126	26
Ozempic	Semaglutide	125	14
Tramadol Hcl	Tramadol Hcl	119	38
Metformin Hcl Er	Metformin Hcl	117	32
Trazodone Hcl	Trazodone Hcl	108	27
Atenolol	Atenolol	106	28
Carvedilol	Carvedilol	95	28
Olmesartan Medoxomil	Olmesartan Medoxomil	95	24
Spironolactone	Spironolactone	95	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	90	31
Famotidine	Famotidine	76	15
Citalopram Hbr	Citalopram Hydrobromide	73	22
Ibuprofen	Ibuprofen	72	22
Metoprolol Tartrate	Metoprolol Tartrate	71	18
Montelukast Sodium	Montelukast Sodium	71	16
Sertraline Hcl	Sertraline Hcl	71	21
Jardiance	Empagliflozin	68	11
Potassium Chloride	Potassium Chloride	67	21
Alendronate Sodium	Alendronate Sodium	66	18
Escitalopram Oxalate	Escitalopram Oxalate	65	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	suppressed
Irbesartan	Irbesartan	62	21
Allopurinol	Allopurinol	61	19
Fluoxetine Hcl	Fluoxetine Hcl	61	17
Prednisone	Prednisone	59	42
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	59	15
Methocarbamol	Methocarbamol	58	16
Tamsulosin Hcl	Tamsulosin Hcl	56	13
Mounjaro	Tirzepatide	52	suppressed
Meloxicam	Meloxicam	51	17
Pantoprazole Sodium	Pantoprazole Sodium	50	18
Januvia	Sitagliptin Phosphate	46	suppressed
Synthroid	Levothyroxine Sodium	46	12
Trulicity	Dulaglutide	46	suppressed
Bupropion Xl	Bupropion Hcl	45	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	15
Mirtazapine	Mirtazapine	44	20
Clonazepam	Clonazepam	42	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	40	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	40	11
Glipizide Er	Glipizide	39	14
Levetiracetam	Levetiracetam	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	12
Lorazepam	Lorazepam	39	suppressed
Pregabalin	Pregabalin	39	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	38	suppressed
Temazepam	Temazepam	38	suppressed
Naproxen	Naproxen	37	13
Venlafaxine Hcl Er	Venlafaxine Hcl	37	12
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	21
Clonidine Hcl	Clonidine Hcl	35	suppressed
Estradiol	Estradiol	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	15
Lidocaine	Lidocaine	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	21
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Azithromycin	Azithromycin	31	26
Bumetanide	Bumetanide	31	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Glipizide	Glipizide	30	suppressed
Valsartan	Valsartan	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	19
Fluconazole	Fluconazole	26	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	18
Diazepam	Diazepam	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Clindamycin Hcl	Clindamycin Hcl	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Niacin Er	Niacin	18	suppressed
Nystatin	Nystatin	18	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Cephalexin	Cephalexin	17	11
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	12
Epinephrine	Epinephrine	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ibu	Ibuprofen	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Clonidine	Clonidine	12	suppressed
Colchicine	Colchicine	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Glyburide	Glyburide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error